The acquisition announcement comes alongside Agilent’s public offering of senior notes amounting to about $850 million, set to mature in 10 years. (Wikimedia Commons) () Diving deeper into the cancer ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results